ATS View
한국어

Vaxcell-Bio Therapeutics KRX:323990KOSDAQ

박셀바이오 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h0
Articles, 7 days12
DART filings, 7 days0
Articles tracked22since Sep 11

In Q2 2026, Vaxcell-Bio Therapeutics reported revenue of ₩1.6bn, down 18.2% year on year, and an operating loss of ₩5.0bn. Vaxcell-Bio Therapeutics (박셀바이오) appeared in 12 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 28 with 9 articles. The most common catalyst was tech & capacity (2). It was most often mentioned alongside NK, ISU Abxis and Inventera.

Filing signals 4 quarters of losses Screener

Vaxcell-Bio Therapeutics quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩1.6bn-18.2%−₩5.0bn−₩4.0bn
Q1 2026₩1.5bn-10.7%−₩4.6bn−₩4.0bn
Q4 2025 derived₩1.7bn-5.7%−₩3.6bn
margin −214.9%		−₩4.2bn
Q3 2025₩1.7bn+242.6%−₩3.4bn
margin −208.1%		−₩2.7bn
Q2 2025₩2.0bn+6692.4%−₩4.1bn
margin −206.7%		−₩3.8bn
Q1 2025₩1.7bn+6355.0%−₩4.3bn
margin −250.4%		−₩2.6bn
Q4 2024 derived₩1.8bn–−₩4.3bn
margin −241.1%		−₩3.3bn
Q3 2024₩483m–−₩3.5bn−₩2.4bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Vaxcell-Bio Therapeutics top stories 2 weeks, by number of outlets

  1. 1
    박셀바이오, 사람·반려동물 암 치료 동종 CAR-NK 연구 성과 발표
    5 outlets · 5 articlesFirst report Sep 28 09:58 데일리한국NK
  2. 2
    박셀바이오, 대만 레버 제네틱스와 동물용의약품 개발 협력
    2 outlets · 2 articlesFirst report Sep 22 08:20 핀포인트뉴스Partnership
  3. 3
    박셀바이오, 대만 레버제네틱스와 ‘동물용의약품’ 글로벌 협력 강화
    2 outlets · 2 articlesFirst report Sep 22 09:38 더바이오
  4. 4
    이제중 박셀바이오 대표, 암면역치료 연구 공로로 전남대병원장 표창
    2 outlets · 2 articlesFirst report Sep 21 10:25 PRESS9
  5. 5
    박셀바이오, 다발골수종·반려견 암 대상 CAR-NK 연구 공개
    2 outlets · 2 articlesFirst report Sep 28 09:58 PRESS9NK
  6. 6
    박셀바이오, VCB-1102 위험도 조정에도 ‘임상연구’ 신청한 까닭
    1 outlets · 2 articlesFirst report Sep 29 08:16 이데일리

Latest Vaxcell-Bio Therapeutics news Korean headlines